Most Read Articles
Dr. Joseph Delano Fule Robles, 12 Feb 2019

A team of investigators from the University of Hong Kong (HKU) identified high-risk Epstein Barr virus (EBV) variants present in 97 percent of nasopharyngeal carcinoma (NPC) cases.

02 Feb 2019
Use of statins following diagnosis of hepatocellular carcinoma appears to confer survival advantage, a study reports.
Stephen Padilla, 04 Feb 2019
Insulin plays an aetiological role in renal cell carcinoma (RCC), while obesity or having an elevated diastolic (DBP), but not systolic (SBP), blood pressure increases RCC risk, according to a recent study.
Roshini Claire Anthony, 07 Feb 2019

A once-daily dose of sorafenib may improve progression-free survival (PFS) in patients with desmoid tumours, a condition that currently has no standard-of-care treatment, according to a phase III trial.

Excerpts from the MY-COMPASSION Expert Meeting

30 Jan 2019
BTcP is defined as: “A transient exacerbation of pain that occurs either spontaneously, or in relation to a specific predictable or unpredictable trigger, despite relatively stable and adequately controlled background pain”.1,2 While there are various pain profiles associated with BTcP, a BTcP episode is typically severe, reaching peak pain intensity within 1–3 minutes from onset and is short in duration (ie, subsiding within 30 minutes).In Malaysia, opioids such as oral immediate-release(IR), intravenous (IV) and subcutaneous (SC) morphine are prescribed as ‘rescue’ medications for BTcP.2 IR opioids reach peak concentrations around 1 hour post-administration,and have a half-life of 3–6 hours, which may be suitable for longer duration BTcP episodes, but may not sufficiently address ‘sharp’, short-duration BTcP.2 In contrast, the faster onset of action seen in ROOs (eg, SLF which reaches peak plasma concentrations within 30–60 minutes post-administration) may be better suited for such episodes of BTcP.3,4

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Dr. Joseph Delano Fule Robles, 12 Feb 2019

A team of investigators from the University of Hong Kong (HKU) identified high-risk Epstein Barr virus (EBV) variants present in 97 percent of nasopharyngeal carcinoma (NPC) cases.

02 Feb 2019
Use of statins following diagnosis of hepatocellular carcinoma appears to confer survival advantage, a study reports.
Stephen Padilla, 04 Feb 2019
Insulin plays an aetiological role in renal cell carcinoma (RCC), while obesity or having an elevated diastolic (DBP), but not systolic (SBP), blood pressure increases RCC risk, according to a recent study.
Roshini Claire Anthony, 07 Feb 2019

A once-daily dose of sorafenib may improve progression-free survival (PFS) in patients with desmoid tumours, a condition that currently has no standard-of-care treatment, according to a phase III trial.